1. PRR. Big year ahead with Nasdaq listing coming and phase 2b/3 to kick off. Look for additional funding out of U.S to come as well.
2. UCL. Namibian phosphate jv wit MAK highly profitable and feasability study underway. Production within 12 > 18 months. Also throw in the left field return of their Iran project.
3. GNI. Will be kicking off their drill program at the jutson rocks/mt cornell/mt venn projects in late april after ground vtem n soil sampling. Very undervalued wit both AUC and GOR within close proximity. Gni's 7 mill market cap has plenty of upside.
4. ANP. Expecting a big year from this little biotech. Partnership with the Nasdaq listed isis provides ANP with a platform to key antisense technology. Surprise packet this year and could move very soon.
5. CFR. Gold gold gold. Madagascar. Should see a turn around story here.
